TNC and glioblastoma: Other examples are GBI-10 targeting malignancy-related tenascin-C in human GBM; and S6-1b that selectively targets human glioma cell line SHG44 and has shown uptake in GBM mice within 4 h after intravenous (i.v.)administration [76,91].